BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24417819)

  • 1. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.
    Avitzur Y; Guo C; Mastropaolo LA; Bahrami E; Chen H; Zhao Z; Elkadri A; Dhillon S; Murchie R; Fattouh R; Huynh H; Walker JL; Wales PW; Cutz E; Kakuta Y; Dudley J; Kammermeier J; Powrie F; Shah N; Walz C; Nathrath M; Kotlarz D; Puchaka J; Krieger JR; Racek T; Kirchner T; Walters TD; Brumell JH; Griffiths AM; Rezaei N; Rashtian P; Najafi M; Monajemzadeh M; Pelsue S; McGovern DP; Uhlig HH; Schadt E; Klein C; Snapper SB; Muise AM
    Gastroenterology; 2014 Apr; 146(4):1028-39. PubMed ID: 24417819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.
    Dhingani N; Guo C; Pan J; Li Q; Warner N; Jardine S; Leung G; Kotlarz D; Gonzaga-Jauregui C; Klein C; Snapper SB; Navas-López VM; Muise AM
    Sci Rep; 2020 Oct; 10(1):18648. PubMed ID: 33122718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.
    Chen R; Giliani S; Lanzi G; Mias GI; Lonardi S; Dobbs K; Manis J; Im H; Gallagher JE; Phanstiel DH; Euskirchen G; Lacroute P; Bettinger K; Moratto D; Weinacht K; Montin D; Gallo E; Mangili G; Porta F; Notarangelo LD; Pedretti S; Al-Herz W; Alfahdli W; Comeau AM; Traister RS; Pai SY; Carella G; Facchetti F; Nadeau KC; Snyder M; Notarangelo LD
    J Allergy Clin Immunol; 2013 Sep; 132(3):656-664.e17. PubMed ID: 23830146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency.
    Lemoine R; Pachlopnik-Schmid J; Farin HF; Bigorgne A; Debré M; Sepulveda F; Héritier S; Lemale J; Talbotec C; Rieux-Laucat F; Ruemmele F; Morali A; Cathebras P; Nitschke P; Bole-Feysot C; Blanche S; Brousse N; Picard C; Clevers H; Fischer A; de Saint Basile G
    J Allergy Clin Immunol; 2014 Dec; 134(6):1354-1364.e6. PubMed ID: 25174867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with multiple intestinal atresia and combined immunodeficiency.
    Agarwal NS; Northrop L; Anyane-Yeboa K; Aggarwal VS; Nagy PL; Demirdag YY
    J Clin Immunol; 2014 Aug; 34(6):607-10. PubMed ID: 24931897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Jardine S; Anderson S; Babcock S; Leung G; Pan J; Dhingani N; Warner N; Guo C; Siddiqui I; Kotlarz D; Dowling JJ; Melnyk RA; Snapper SB; Klein C; Thiagarajah JR; Muise AM
    Gastroenterology; 2020 Mar; 158(4):1000-1015. PubMed ID: 31743734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Homozygous
    Mou W; Yang S; Guo R; Fu L; Zhang L; Guo W; Du J; He J; Ren Q; Hao C; Gui J; Huang J
    Front Immunol; 2021; 12():759308. PubMed ID: 34975848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTC7A mutations disrupt intestinal epithelial apicobasal polarity.
    Bigorgne AE; Farin HF; Lemoine R; Mahlaoui N; Lambert N; Gil M; Schulz A; Philippet P; Schlesser P; Abrahamsen TG; Oymar K; Davies EG; Ellingsen CL; Leteurtre E; Moreau-Massart B; Berrebi D; Bole-Feysot C; Nischke P; Brousse N; Fischer A; Clevers H; de Saint Basile G
    J Clin Invest; 2014 Jan; 124(1):328-37. PubMed ID: 24292712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Intestinal Pseudo-Obstruction and Lymphoproliferative Syndrome as a Novel Phenotype Associated With Tetratricopeptide Repeat Domain 7A Deficiency.
    El-Daher MT; Lemale J; Bruneau J; Leveau C; Guerin F; Lambert N; Diana JS; Neven B; Sepulveda FE; Coulomb-L'Hermine A; Molina T; Picard C; Fischer A; de Saint Basile G
    Front Immunol; 2019; 10():2592. PubMed ID: 31787977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Gastrointestinal Histopathology in Patients With Tetratricopeptide Repeat Domain 7A (TTC7A) Germline Mutations: A Rare Condition Leading to Multiple Intestinal Atresias, Severe Combined Immunodeficiency, and Congenital Enteropathy.
    Dannheim K; Ouahed J; Field M; Snapper S; Raphael BP; Glover SC; Bishop PR; Bhesania N; Kamin D; Thiagarajah J; Goldsmith JD
    Am J Surg Pathol; 2022 Jun; 46(6):846-853. PubMed ID: 34985046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTC7A: Steward of Intestinal Health.
    Jardine S; Dhingani N; Muise AM
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):555-570. PubMed ID: 30553809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort.
    Fernandez I; Patey N; Marchand V; Birlea M; Maranda B; Haddad E; Decaluwe H; Le Deist F
    Medicine (Baltimore); 2014 Dec; 93(29):e327. PubMed ID: 25546680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous mutations in TTC7A cause familial multiple intestinal atresias and severe combined immunodeficiency.
    Yang W; Lee PP; Thong MK; Ramanujam TM; Shanmugam A; Koh MT; Chan KW; Ying D; Wang Y; Shen JJ; Yang J; Lau YL
    Clin Genet; 2015 Dec; 88(6):542-9. PubMed ID: 25534311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.
    Dhillon SS; Fattouh R; Elkadri A; Xu W; Murchie R; Walters T; Guo C; Mack D; Huynh HQ; Baksh S; Silverberg MS; Griffiths AM; Snapper SB; Brumell JH; Muise AM
    Gastroenterology; 2014 Sep; 147(3):680-689.e2. PubMed ID: 24931457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
    Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
    Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutation of TTC7A mimicking tricho-hepato-enteric (SD/THE) syndrome in a patient with very-early onset inflammatory bowel disease.
    Neves JF; Afonso I; Borrego L; Martins C; Cordeiro AI; Neves C; Lacoste C; Badens C; Fabre A
    Eur J Med Genet; 2018 Apr; 61(4):185-188. PubMed ID: 29174094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutations of the
    Lien R; Lin YF; Lai MW; Weng HY; Wu RC; Jaing TH; Huang JL; Tsai SF; Lee WI
    Front Immunol; 2017; 8():1066. PubMed ID: 28936210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Exonic Deletions in TTC7A in a Newborn with Multiple Intestinal Atresia and Combined Immunodeficiency.
    Saunders JR; Lehman A; Turvey SE; Pan J; Rajcan-Separovic E; Muise AM; Bush JW
    J Clin Immunol; 2019 Aug; 39(6):616-619. PubMed ID: 31342292
    [No Abstract]   [Full Text] [Related]  

  • 20. Variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.
    Ouahed J; Kelsen JR; Spessott WA; Kooshesh K; Sanmillan ML; Dawany N; Sullivan KE; Hamilton KE; Slowik V; Nejentsev S; Neves JF; Flores H; Chung WK; Wilson A; Anyane-Yeboa K; Wou K; Jain P; Field M; Tollefson S; Dent MH; Li D; Naito T; McGovern DPB; Kwong AC; Taliaferro F; Ordovas-Montanes J; Horwitz BH; Kotlarz D; Klein C; Evans J; Dorsey J; Warner N; Elkadri A; Muise AM; Goldsmith J; Thompson B; Engelhardt KR; Cant AJ; Hambleton S; Barclay A; Toth-Petroczy A; Vuzman D; Carmichael N; Bodea C; Cassa CA; Devoto M; Maas RL; Behrens EM; Giraudo CG; Snapper SB
    J Crohns Colitis; 2021 Nov; 15(11):1908-1919. PubMed ID: 33891011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.